239 related articles for article (PubMed ID: 37295542)
1. Immunopathogenesis of Behçet's disease.
Al-Obeidi AF; Nowatzky J
Clin Immunol; 2023 Aug; 253():109661. PubMed ID: 37295542
[TBL] [Abstract][Full Text] [Related]
2. Behçet's disease risk-variant HLA-B51/ERAP1-Hap10 alters human CD8 T cell immunity.
Cavers A; Kugler MC; Ozguler Y; Al-Obeidi AF; Hatemi G; Ueberheide BM; Ucar D; Manches O; Nowatzky J
Ann Rheum Dis; 2022 Nov; 81(11):1603-1611. PubMed ID: 35922122
[TBL] [Abstract][Full Text] [Related]
3. Dose HLA-B5, 7, 8, 27, and 51 Antigens Associated to Behcet's disease? A Study in Southwestern Iran.
Rajaei E; Jalali MT; Pezeshki SMS; Rezaeeyan H; Maniati M; Elyasi M; Zayeri ZD
Curr Rheumatol Rev; 2020; 16(2):120-124. PubMed ID: 31533601
[TBL] [Abstract][Full Text] [Related]
4. Behçet's disease: an update on the pathogenesis.
Gül A
Clin Exp Rheumatol; 2001; 19(5 Suppl 24):S6-12. PubMed ID: 11760403
[TBL] [Abstract][Full Text] [Related]
5. Behçet's disease associated with one of the HLA-B51 subantigens, HLA-B* 5101.
Mizuki N; Inoko H; Ando H; Nakamura S; Kashiwase K; Akaza T; Fujino Y; Masuda K; Takiguchi M; Ohno S
Am J Ophthalmol; 1993 Oct; 116(4):406-9. PubMed ID: 8213969
[TBL] [Abstract][Full Text] [Related]
6. Immunopathogenesis of Behçet's disease and treatment modalities.
van der Houwen TB; van Hagen PM; van Laar JAM
Semin Arthritis Rheum; 2022 Feb; 52():151956. PubMed ID: 35038644
[TBL] [Abstract][Full Text] [Related]
7. A strong association between HLA-B*5101 and Behçet's disease in Greek patients.
Mizuki N; Ohno S; Ando H; Chen L; Palimeris GD; Stavropoulos-Ghiokas E; Ishihara M; Goto K; Nakamura S; Shindo Y; Isobe K; Ito N; Inoko H
Tissue Antigens; 1997 Jul; 50(1):57-60. PubMed ID: 9243757
[TBL] [Abstract][Full Text] [Related]
8. Genetics of Behçet's disease: lessons learned from genomewide association studies.
Gül A
Curr Opin Rheumatol; 2014 Jan; 26(1):56-63. PubMed ID: 24257369
[TBL] [Abstract][Full Text] [Related]
9. Primary association of HLA-B51 with Behçet's disease in Ireland.
Kilmartin DJ; Finch A; Acheson RW
Br J Ophthalmol; 1997 Aug; 81(8):649-53. PubMed ID: 9349151
[TBL] [Abstract][Full Text] [Related]
10. Behçet's Disease: A Comprehensive Review on the Role of
Khoshbakht S; Başkurt D; Vural A; Vural S
Int J Mol Sci; 2023 Nov; 24(22):. PubMed ID: 38003572
[TBL] [Abstract][Full Text] [Related]
11. Association of HLA-B51 subtypes and Behçet's disease in Spain.
González-Escribano MF; Rodríguez MR; Walter K; Sanchez-Roman J; García-Lozano JR; Núñez-Roldán A
Tissue Antigens; 1998 Jul; 52(1):78-80. PubMed ID: 9714478
[TBL] [Abstract][Full Text] [Related]
12. Molecular dynamics simulations provide molecular insights into the role of HLA-B51 in Behçet's disease pathogenesis.
Gur M; Golcuk M; Gul A; Erman B
Chem Biol Drug Des; 2020 Jul; 96(1):644-658. PubMed ID: 32691964
[TBL] [Abstract][Full Text] [Related]
13. The Behçet's disease-associated variant of the aminopeptidase ERAP1 shapes a low-affinity HLA-B*51 peptidome by differential subpeptidome processing.
Guasp P; Barnea E; González-Escribano MF; Jiménez-Reinoso A; Regueiro JR; Admon A; López de Castro JA
J Biol Chem; 2017 Jun; 292(23):9680-9689. PubMed ID: 28446606
[TBL] [Abstract][Full Text] [Related]
14. HLA-B*5101 in Greek patients with Behçet's disease.
Koumantaki Y; Stavropoulos C; Spyropoulou M; Messini H; Papademetropoulos M; Giziaki E; Marcomichelakis N; Palimeris G; Kaklamanis P; Kaklamani E
Hum Immunol; 1998 Apr; 59(4):250-5. PubMed ID: 9568801
[TBL] [Abstract][Full Text] [Related]
15. Is Behçet's disease a 'class 1-opathy'? The role of HLA-B*51 in the pathogenesis of Behçet's disease.
Giza M; Koftori D; Chen L; Bowness P
Clin Exp Immunol; 2018 Jan; 191(1):11-18. PubMed ID: 28898393
[TBL] [Abstract][Full Text] [Related]
16. HLA-B51 may serve as an immunogenetic marker for a subgroup of patients with Behçet's syndrome.
Chajek-Shaul T; Pisanty S; Knobler H; Matzner Y; Glick M; Ron N; Rosenman E; Brautbar C
Am J Med; 1987 Oct; 83(4):666-72. PubMed ID: 3314492
[TBL] [Abstract][Full Text] [Related]
17. Association of the MIC-A gene and HLA-B51 with Behçet's disease in Arabs and non-Ashkenazi Jews in Israel.
Cohen R; Metzger S; Nahir M; Chajek-Shaul T
Ann Rheum Dis; 2002 Feb; 61(2):157-60. PubMed ID: 11796403
[TBL] [Abstract][Full Text] [Related]
18. The absence of disease-specific polymorphisms within the HLA-B51 gene that is the susceptible locus for Behçet's disease.
Sano K; Yabuki K; Imagawa Y; Shiina T; Mizuki N; Ohno S; Kulski JK; Inoko H
Tissue Antigens; 2001 Aug; 58(2):77-82. PubMed ID: 11696219
[TBL] [Abstract][Full Text] [Related]
19. HLA-B51 gene and its expression in association with Behçet's Disease in Denizli Province of Turkey.
Atalay A; Yildiz-Demirtepe S; Tatlipinar S; Sanli-Erdoğan B; Cobankara V; Yildirim C; Bağci H; Atalay EO
Mol Biol Rep; 2008 Sep; 35(3):345-9. PubMed ID: 17594535
[TBL] [Abstract][Full Text] [Related]
20. Use of ultrasound biomicroscopy, indocyanine green angiography and HLA-B51 testing as adjunct methods in the appraisal of Behçet's uveitis.
Klaeger AJ; Tran VT; Hiroz CA; Morisod L; Herbort CP
Int Ophthalmol; 2004 Jan; 25(1):57-63. PubMed ID: 15085978
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
